Registry for Systemic Eczema Treatments

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
Johns Hopkins University
Study ID
NCT06136767
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
1 Year - 26 Years
Healthy Volunteers
Not accepted

Study Details

The Registry for Systemic Eczema Therapies (RESET) registry is a database and biospecimen repository for patients with pediatric-onset atopic dermatitis (AD) who have used or will initiate any systemic treatment(s) for AD. The goal of the registry is to enable more efficient research recruitment and data collection as well as timely notification to enrollees about newly FDA-approved treatments for AD.

Key Dates

Start date
Jan 17, 2024
Status verified
Apr 2026
Primary completion
Aug 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
400 participants (estimated)

Arms

  • Arm: Methotrexate
    Participants who have received methotrexate for atopic dermatitis.
  • Arm: Cyclosporine
    Participants who have received cyclosporine for atopic dermatitis.
  • Arm: Mycophenolate mofetil
    Participants who have received mycophenolate mofetil for atopic dermatitis.
  • Arm: Azathioprine
    Participants who have received azathioprine for atopic dermatitis.
  • Arm: Dupilumab
    Participants who have received dupilumab for atopic dermatitis.
  • Arm: Tralokinumab
    Participants who have received tralokinumab for atopic dermatitis.
  • Arm: Upadacitinib
    Participants who have received upadacitinib for atopic dermatitis.
  • Arm: Abrocitinib
    Participants who have received abrocitinib for atopic dermatitis.

Primary Outcome Measure

Treatment effectiveness as assessed by the change in Investigator's Global Assessment (IGA) Scores [ Time Frame: 3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Johns Hopkins UniversityBaltimoreMaryland21218
Zeena Mestari, BA
[email protected]
848-702-4101
Joy Wan, MD MSCE (PRINCIPAL_INVESTIGATOR)

Find similar trials in Baltimore, MD

By condition
Atopic dermatitis / eczema
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
Johns Hopkins University· Baltimore, MD

Related Studies